Breaking News
Get 45% Off 0
💯 ProPicks AI strategy hits +100% returns – more than twice the returns of the S&P 500
Unlock Stocks
Close

Squad – Makro N (0P0000NI17)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
240.890 -1.320    -0.54%
06:00:00 - Closed. Currency in EUR
Type:  Fund
Market:  Luxembourg
ISIN:  LU0490817821 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 537.59M
Squad Capital - Squad Makro N 240.890 -1.320 -0.54%

0P0000NI17 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Squad Capital - Squad Makro N (0P0000NI17) fund. Our Squad Capital - Squad Makro N portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 14.540 14.550 0.010
Shares 79.680 79.680 0.000
Bonds 5.000 5.000 0.000
Convertible 0.850 0.850 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 14.389 16.237
Price to Book 2.157 2.423
Price to Sales 1.260 1.823
Price to Cash Flow 8.753 9.881
Dividend Yield 2.576 2.477
5 Years Earnings Growth 9.322 10.735

Sector Allocation

Name  Net % Category Average
Healthcare 17.280 11.848
Consumer Cyclical 15.540 11.951
Technology 14.120 19.035
Energy 10.530 4.895
Communication Services 9.900 7.525
Financial Services 9.770 16.445
Basic Materials 8.810 6.978
Consumer Defensive 6.600 7.481
Utilities 3.980 3.183
Industrials 3.150 12.290
Real Estate 0.300 2.831

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Australasia
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 99

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Amazon.com US0231351067 1.98 205.01 -0.34%
  Alphabet A US02079K3059 1.89 171.61 -0.15%
  Uber Tech US90353T1007 1.87 84.16 -0.17%
  Oracle US68389X1054 1.59 165.37 +1.52%
  Roche Holding Participation CH0012032048 1.57 265.50 +2.04%
  Booking US09857L1089 1.49 5,514.13 +0.22%
  Merck&Co US58933Y1055 1.44 76.82 +0.55%
  Verizon US92343V1044 1.41 43.93 +1.37%
  Microsoft US5949181045 1.40 459.59 +0.20%
  GSK plc GB00BN7SWP63 1.36 1,507.00 +3.50%

Top Equity Funds by Axxion S.A.

  Name Rating Total Assets YTD% 3Y% 10Y%
  Squad Capital Squad Makro Seed 558.57M -4.81 1.89 5.91
  LU1272153831 525.54M -7.45 3.47 -
  LU0329325095 525.54M -7.71 2.65 5.35
  Squad Capital Squad Value A 163.44M 6.70 5.36 6.48
  Squad Capital Squad Value B 163.44M 6.55 5.31 6.15
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000NI17 Comments

Write your thoughts about Squad – Makro N
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email